Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. Revenue 2019–2024
Jade Biosciences Inc. annual/quarterly revenue history and growth rate from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Jade Biosciences Inc. revenue for the quarter ending December 31, 2024 was 0.
- Jade Biosciences Inc. revenue for the twelve months ending December 31, 2024 was 0.
- Jade Biosciences Inc. annual revenue for 2024 was 0.
- Jade Biosciences Inc. annual revenue for 2023 was 0.
- Jade Biosciences Inc. annual revenue for 2022 was 0.
- Jade Biosciences Inc. annual revenue for 2021 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. (AVTE) — Frequently Asked Questions
Jade Biosciences Inc. (AVTE) is a publicly traded US company. Explore AVTE's stock price, financial statements, earnings history, margins and key ratios below.
What is the AVTE stock price?
AVTE trades at $15.26 (+0.26% on the day).
Is AVTE profitable?
In fiscal 2024, Jade Biosciences Inc. reported net income of -$70M.